Report
EUR 13.24 For Business Accounts Only

HAPVIDA PARTIC reduced its risk exposure resulting in an upgrade to Slightly Positive

HAPVIDA PARTIC (BR), a company active in the Life Insurance industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date February 19, 2021, the closing price was BRL 17.24 and its potential was estimated at BRL 21.15.
Underlying
Hapvida Participacoes e Investimentos SA

Hapvida Participacoes e Investimentos SA (Hapvida) is a Brazil-based holding healthcare company. The Company and its subsidiaries main activities are the coverage of costs of medical, hospital and dental care of its associates, the provision of medical, hospital and dentistry services and examinations and diagnoses per image. Hapvida has different healthcare facilities such as hospitals, clinics or diagnostic imaging units. The Company operates in the Northeast of Brazil, in more than 10 states such as Alagoas, Amazonas, Bahia, Pernambuco, Rio Grande do Norte, Sergipe, among others.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch